Cargando…
Post-vaccination seropositivity against SARS-CoV-2 in peruvian health workers vaccinated with BBIBP-CorV (Sinopharm)
OBJECTIVE: To estimate the prevalence of post-vaccination seropositivity against SARS-CoV-2 and identify its predictors in Peruvian Social Health Insurance (EsSalud) personnel in 2021. METHODS: We conducted a cross-sectional study in a representative simple stratified sample of EsSalud workers. We e...
Autores principales: | Cvetkovic-Vega, Aleksandar, Urrunaga-Pastor, Diego, Soto-Becerra, Percy, Figueroa-Montes, Luis E., Fernandez-Bolivar, Lizette, Alvizuri-Pastor, Sergio, Oyanguren-Miranda, Martin, Neyra-Vera, Ibeth, Carrillo-Ramos, Elizabeth, Sagástegui, Arturo, Contreras-Macazana, Roxana, Lecca-Rengifo, Diana, Grande-Castro, Nikolai, Apolaya-Segura, Moises, Maguina, Jorge L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Authors. Published by Elsevier Ltd.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9710108/ https://www.ncbi.nlm.nih.gov/pubmed/36462747 http://dx.doi.org/10.1016/j.tmaid.2022.102514 |
Ejemplares similares
-
Humoral response after a BNT162b2 heterologous third dose of COVID-19 vaccine following two doses of BBIBP-CorV among healthcare personnel in Peru
por: Montero, Stephanie, et al.
Publicado: (2023) -
Autoimmune encephalitis after BBIBP-CorV (Sinopharm) COVID-19 vaccination: a case report
por: Vences, Miguel A., et al.
Publicado: (2022) -
Persistence of immune responses to the Sinopharm/BBIBP‐CorV vaccine
por: Jeewandara, Chandima, et al.
Publicado: (2022) -
Thrombotic thrombocytopenia After Sinopharm BBIBP‐CorV COVID‐19 vaccination
por: Hosseinzadeh, Rezvan, et al.
Publicado: (2022) -
Abducense nerve palsy following BBIBP-CorV (Sinopharm) COVID-19 vaccine
por: Khalili, M.R., et al.
Publicado: (2022)